Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Ocala. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Ocala at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This study will investigate the safety, tolerability, and antitumor activity of S095029 (anti-NKG2A antibody) in combination with pembrolizumab in in microsatellite instability-high/Defective mismatch repair (MSI-H/dMMR) locally advanced unresectable or metastatic gastric /GEJ adenocarcinomas.
Sponsor: Servier Bio-Innovation LLC
Check if you qualify for this gastric cancer clinical trial in Ocala, FL
If you're searching for gastric cancer treatment options in Ocala, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ocala research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.